Literature DB >> 7022833

Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.

P L Weiden, N Flournoy, J E Sanders, K M Sullivan, E D Thomas.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7022833

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  23 in total

1.  The new stem cell biology.

Authors:  Peter J Quesenberry; Gerald A Colvin; Jean-Francois Lambert; Angela E Frimberger; Mark S Dooner; Christina I Mcauliffe; Caroline Miller; Pamela Becker; Evangelis Badiavas; Vincent J Falanga; Gerald Elfenbein; Lawrence G Lum
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 2.  Allogeneic hematopoietic cell transplantation: the state of the art.

Authors:  Boglarka Gyurkocza; Andrew Rezvani; Rainer F Storb
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

Review 3.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

Review 4.  Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.

Authors:  Aravind Ramakrishnan; Brenda M Sandmaier
Journal:  Expert Rev Hematol       Date:  2010-02-01       Impact factor: 2.929

Review 5.  Bone marrow transplantation. Part I--Allogeneic.

Authors:  N J Chao; K G Blume
Journal:  West J Med       Date:  1989-12

6.  Adult acute leukaemia: prospects for cure.

Authors:  J M Goldman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-07

Review 7.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

8.  Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD.

Authors:  Y Zeng; J Stokes; S Hahn; E Hoffman; E Katsanis
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

9.  Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.

Authors:  S Mielke; M Lutz; J Schmidhuber; M Kapp; D Ditz; J Ammer; H Einsele; G U Grigoleit; E Holler; D Wolff
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

Review 10.  Acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  C Perreault; M Gyger; J Boileau; Y Bonny; S Cousineau; M Lacombe; R Lavallee; E Tawil; G D'Angelo
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.